
Torrent Pharma to acquire 3 anti-diabetes brands from Boehringer Ingelheim
Torrent will acquire Cospiaq (empagliflozin) Cospiaq Met (empagliflozin + metformin) and Xilingio (empagliflozin + linagliptin). Shares of Torrent Pharmaceuticals Ltd ended at ₹3,346.85, down by…








